Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- OG-6219Phase 21 trial
Organon and Co · Endometriosis
- OHB-607Mecasermin RinfabatePhase 21 trial
OHB Neonatology Ltd. · Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage
- OKI-179Phase 21 trial
OnKure, Inc. · RAS Mutation, NRAS Gene Mutation, Melanoma
- OLX72021Phase 21 trial
Olix Pharmaceuticals, Inc. · Androgenetic Alopecia (AGA)
- OM-85Phase 21 trial
OM Pharma SA · Recurrent Wheezing, Wheezing Lower Respiratory Illness
- OMT-28Phase 21 trial
Omeicos Therapeutics GmbH · Primary Mitochondrial Disease
- ONO-4538HSCPhase 21 trial
Ono Pharmaceutical Co., Ltd. · Pediatric Malignant Solid Tumor and Epithelioid Sarcoma
- ONO-4915Phase 21 trial
Ono Pharmaceutical Co., Ltd. · Sjogren's Disease
- ONO-7703Phase 21 trial
Ono Pharmaceutical Co., Ltd. · Pan-tumor
- OpCT-001Phase 21 trial
BlueRock Therapeutics · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), Usher Syndrome
- OPK-88006Phase 21 trial
OPKO Health, Inc. · MASH
- OPM-101Phase 21 trial
Oncodesign Precision Medicine · Advanced Melanoma
- OPT101Phase 21 trial
Op-T LLC · Type I Diabetes
- OR502Phase 21 trial
OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm
- ORIC-114Phase 21 trial
ORIC Pharmaceuticals · Solid Tumors
- OriCAR-017Phase 21 trial
OriCell Therapeutics Co., Ltd. · Relapsed and/or Refractory Multiple Myeloma
- ORJ-001Phase 21 trial
Oorja Bio, Inc. · Idiopathic Pulmonary Fibrosis
- OrticumabMLDL1278a, BI204Phase 21 trial
Abcentra · Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation
- OSE-279Phase 21 trial
OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
- OST31-164Phase 21 trial
Emerald Clinical Inc. · Bone Cancer
- OTP-01Phase 21 trial
Ottimo Pharma Limited · Advanced Solid Tumors
- OVX836Phase 21 trial
Osivax · Influenza
- OXU-001DEXAspheresPhase 21 trial
Oxular Limited · Diabetic Macular Edema
- PAL-119Phase 21 trial
Paulex Bio Inc. · Healthy Volunteers and Diabetes Participants
- PALI-2108Phase 21 trial
Palisade Bio · Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
- paxalisibSVG103Phase 21 trial
Sovargen · Focal Cortical Dysplasia, Tuberous Sclerosis Complex (TSC), Hemimegalencephaly
- PBGM01Phase 21 trial
Gemma Biotherapeutics · GM1 Gangliosidosis, GM1 Gangliosidosis, Type I, GM1 Gangliosidosis, Type 2
- PBP1510Phase 21 trial
Prestige Biopharma Limited · Pancreatic Cancer
- PBSS1113Phase 21 trial
Chaser Therapeutics, Inc. · Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)
- PCV1515-valent pneumococcal conjugate vaccinePhase 21 trial
Pfizer · Pneumococcal Disease
- PDC-1421Phase 21 trial
BioLite, Inc. · Major Depressive Disorder
- PDFE-2304Phase 21 trial
PDFE Pharma Innovations FZCO · Alopecia, Androgenetic, Baldness, Androgenetic Alopecia (AGA)
- PE0105Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Advanced Solid Tumors
- PE0116Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Advanced Solid Tumors
- PegenzileukinSAR444245Phase 21 trial
Sanofi · Plasma Cell Myeloma Refractory
- PEGPH20Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- PempulimabPhase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Nasopharyngeal Carcinoma
- PepinemabPhase 21 trial
Vaccinex Inc. · Metastatic Pancreatic Adenocarcinoma
- PF-0704091Phase 21 trial
Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
- PF-07264660Phase 21 trial
Pfizer · Atopic Dermatitis
- PF-07328948Phase 21 trial
Pfizer · Heart Failure
- PF-07868489Phase 21 trial
Pfizer · Pulmonary Arterial Hypertension
- PF-07976016Phase 21 trial
Pfizer · Obesity
- PF-08049820Phase 21 trial
Pfizer · Atopic Dermatitis, Eczema, Atopic
- PF-08154225Phase 21 trial
Pfizer · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis
- PF-08653945Phase 21 trial
Pfizer · Overweight, Obesity, Overweight and/or Obesity
- PG043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
Genelux Corporation · Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer
- PIPE-307Phase 21 trial
Johnson & Johnson (Janssen) · Relapsing Remitting Multiple Sclerosis
- PIPE-791Phase 21 trial
Contineum Therapeutics · Idiopathic Pulmonary Fibrosis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.